Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.

Marchini, Antonio; Daeffler, Laurent; Pozdeev, Vitaly I; Angelova, Assia; Rommelaere, Jean

Marchini, Antonio; Daeffler, Laurent; Pozdeev, Vitaly I; Angelova, Assia; Rommelaere, Jean.

Afiliação

Marchini A; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Daeffler L; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany.
Pozdeev VI; Université de Strasbourg, IPHC, Strasbourg, France.
Angelova A; CNRS, UMR7178, Strasbourg, France.
Rommelaere J; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg.

Front Immunol ; 10: 1848, 2019.

Article em En | MEDLINE | ID: mdl-31440242

Assuntos

Parvovirus H-1/imunologia; Neoplasias/imunologia; Neoplasias/terapia; Terapia Viral Oncolítica; Vírus Oncolíticos/imunologia; Microambiente Tumoral/imunologia; Humanos

Palavras-chave

H-1PV; checkpoint blockade; combination therapy; immunogenic cell death; immunotherapy; oncolytic viruses; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Terapia Viral Oncolítica / Parvovirus H-1 / Microambiente Tumoral / Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google